Health

Smoking cessation drug proves effective

NEWS IN BRIEF — Posted Sept. 4, 2006

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

A drug recently approved by the Food and Drug Administration as a smoking cessation aid appears to be effective in both the short and long term for smokers trying to quit, according to a study in the Aug. 14/28 Archives of Internal Medicine.

The new drug, varenicline tartrate, made by Pfizer and marketed as Chantix, mimics the effects of nicotine to help offset cravings. In the presence of nicotine, it helps suppress some of the reinforcing effects of smoking.

Healthy smokers ages 18 to 65 were randomly assigned to get either varenicline in a variety of doses for six weeks -- 0.3 mg a day, 1 mg a day or 1 mg twice daily and a placebo for one week; or 150 mg of sustained-release bupropion hydrochloride twice daily for seven weeks or a placebo for seven weeks. There were 128 smokers in each group. The researchers report that the varenicline 1 mg twice daily dose triggered the highest rate of continuous abstinence. Four-week quit rates ranged from 48% for those on the high-dose varenicline to 17% for those on the placebo. Long-term quit rates ranging from four weeks to one year were 14% for the varenicline group and 5% for those on placebo.

Note: This item originally appeared at http://www.ama-assn.org/amednews/2006/09/04/hlbf0904.htm.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn